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Abstract: 
       The current study was conducted at the Center for Diabetes and Endocrinology of the 
Health Directorate in Thi- Qar province, during the period from October 2013 to May 2014. 
The study aimed and evaluate immune status of diabetes type I patients by measuring the 
levels of  immunoglobulins ( IgM, IgG, IgA ) by single redial immune diffusion (SRID) and 
the study included test  phagocytic cells on phagocytosis (coefficient  of phagocytosis) and 
measurement hematological parameters(red blood cells count , hemoglobin, packed cell 
volume and count the total and differential white blood cells) . The study included a total of 
100 patients with type I diabetes (51 males) and (49 females) and  there aged between 1-40 
years. Levels were measured in serum immunoglobulins  for 20 a sample of patients with type 
I diabetes, also examined the levels of immunoglobulins  in the serum of 10 samples from 
healthy people in the control group. The results of the statistical analysis showed high 
significant increase  (P ≤ 0.001) in the immunoglobulins in  serum IgM,, IgG IgA in patients 
with type I diabetes compared with healthy control group . Decrease coefficient phagocytosis 
was significantly (P ≤ 0.001) in all patients with diabetes mellitus type I compared a group of 
control, either with respect to the hematological parameters  have explained the results of the 
current study, the lack of significant differences( P ≤ 0.05) in the rates of the values of the 
RBCs and Hb and PCV in all patients diabetes type I, compared with the control group, also 
increased the rate of counting the total of WBCs and count differential cell lymphocytes, 
eosinophil , basophil, and monocyte  (P ≤ 0.001) in patients with diabetes mellitus type I 
compared with healthy people in the control group .                                                                     
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Introduction:                                                 
Diabetes mellitus type 1 (also known as 
type 1 diabetes or T1DM ,formerly insulin 
dependent diabetes mellitus (IDDM) , or 
juvenile diabetes 
[1,2]
 . T1DM  is a chronic 
systemic metabolic disorders characterized 
by increased levels of glucose in the blood 
(hyperglycemia) and abnormalities in the 
metabolism of protein 
[3]
 , that results from  
the autoimmune destruction of insulin-
producing pancreatic beta  cells 
[4,5]
 , by 
autoreactive T-lymphocyte 
[6]
 , and that 
leading deficiency of insulin 
[7]
 , and this 
disease was once thought to be mediated 
exclusively by CD4_ T cells and is now 
recognized as one in which autoreactive 
CD8_ T cells play a fundamental 
pathogenic role 
[8]
 . The etiology of T1D is 
complex and involves both genetic and 
environmental factors which play 
important roles 
[9,10,11]
 . A permissive 
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genetic background is required for the 
development of the islet autoimmune 
process generating antibodies (Ab) against 
insulin insulin auto antibodies  (IAA), 
glutamic acid decarboxylase isoform 65 
(GADA65-Ab), and protein tyrosine 
phosphatase (IA2) 
[12,13]
 . 
         The incidence of T1DM is reported 
to be increasing by 3-5% per year, and the 
number of people with diabetes is 
estimated to reach 380 million by 2025 
[14]
 
. The incidence rate of childhood T1DM is 
increasing dramatically in many countries 
over the past 20 years 
[15]
 .The classical 
symptoms of type 1 diabetes include 
polyuria (frequent urination),polydipsia 
(increased thirst),  Xerostomia  (dry 
mouth), polyphagia (increased hunger), 
fatigue, and weight loss 
[16,17]
 .  
         The diabetic complications are 
divided into microvascular (nephropathy, 
retinopathy, and neuropathy) and 
macrovascular (cardiovascular) disease. 
Once considered a part of type 1 diabetes 
itself, the observation that similar 
complications also arise in patients with 
secondary diabetes led to the view that 
complications are caused by the 
hyperglycaemic milieu. The blood glucose 
values that define diabetes itself are set by 
the risk of diabetic microvascular 
complications  
[18,19]
 . 
 
 Immunoglobulins ( Ig ) :  
         The immune system generates 
billions of different antibody molecules by 
mature B cells which are capable of 
secreting antibodies and expressing B cell 
receptors on their  cell  surfaces  
[20,21]
 . Ig 
antibodies are large proteins composed of 
four polypeptide chains (two identical 
heavy chains  and  two  identical  light  
chains)  joined  together  by  disulphide  
bonds.  Each  Ig recognizes  a  specific  
antigen  unique  to  its  target and  is  used  
by  the  immune  system  to locate  and  
destroy  invading  microorganisms 
[22]
 . 
Serum immunoglobulin  levels  provide  
key  information  on  the  humoral  
immune  status 
[23,24]
 .  
        Immunoglobulin M (IgM) : 
        It is the first isotype to be generated  
during  a  primary  immune  response  and 
it is predominates in immune response to 
most antigens. Its pentameric structure is a  
highly  effective  activator  of complement.    
IgM is the first immunoglobulin class to be 
synthesized by the neonate .  IgM  is  
larger  than  IgG  with  a  molecular mass 
of approximately 950 kDa that makes up 
about 8% of the antibody in the serum 
[25,26]
 . 
       Immunoglobulin G (IgG)  : 
       Immunoglobulin G is a major effector 
molecule of the humoral immune response 
in man, accounts for about 80% of the total 
immunoglobulins in plasma of healthy 
individuals . The IgG (150 kD) is 
composed of two light chains and two 
heavy chains (g). The four polypeptide 
chains are covalently held together by 
disulfide bonds . It's the major antibody in 
the blood. Human IgG consists of four 
subclasses (isotypes),which are numbered 
in order of their serum concentrations 
(IgG1, IgG2, IgG3, and IgG4). IgG express 
predominant activity during a secondary 
antibody response. IgG antibodies have a 
relatively high affinity and persist in the 
circulation for a long time  
[26,27]
 . 
  Immunoglobulin A (IgA ) :  
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        The human body produces more IgA 
daily than any other antibody isotype .  IgA  
has  an  approximate  molecular  mass  of  
160  kDa  and,  after  IgG,  is  the second 
most prevalent antibody in the 
bloodstream. It  constitutes about 13% of 
the antibody in human serum, but it is the 
predominant class of antibody in 
extravascular secretions. IgA is the main 
effector of the mucosal immune system 
and provides an important first line of 
defense against most pathogens that invade 
the body at a mucosal surface 
[28]
. IgA is 
found in most external secretions that 
bathe mucosal surfaces, for example, 
saliva, tears, mucus and breast milk, and is 
principally dimeric (i.e. composed of two 
monomeric IgA subunits and  J chain) The 
total  area  of  these  mucosal  surfaces  is  
vast  and  they  are  vulnerable  to  
exposure  to pathogens 
[29].
  
Phagocytosis : 
       The process of phagocytosis involves 
the internalization of large particles 
(≥0.5µm) , phagocytosis is limited to 
specific Phagocytic cells such as 
monocytes , macrophage and neutrophils. 
These cells are vital to both the innate and 
adaptive immune systems .The innate 
functions of these molecules (specifically 
,the internalization  and digestion of 
pathogens bound to receptor on the cell 
surface ) represent  the first line of defense 
against  invading microorganisms . In the 
adaptive response , B cell produce antigen-
specific antibodies lead to the opsonization 
of the pathogen 
[27]
 . 
Materials & methods :  
study desigen :  
      This study was performed  on (100) 
Iraqi patients with T1DM patients, who 
attended the consultant clinic for Type 1 
diabetes mellitus in endocrine and diabetic 
center in Al-Nasiriya city in the period 
from beginning October  2013 to  end May   
2014. This study included too (30) person  
apparently healthy individuals as a control 
group. , who have no history or clinical 
evidence of T1DM or any other chronic 
disease, and no obvious abnormalities .  
 
 Blood Samples Collection:  
       Blood samples were collected by 
venipuncture from 100 patients and 30 
controls (five milliliters of venous blood) 
were drawn by  disposable syringe under 
aseptic technique. were placed in a sterile 
plane tube and allowed to clot, then serum 
was separated by centrifugation at 4000 
rpm  for 15 minutes. The serum was stored 
at -10 C˚ . These  sera (20 T1DM patients 
and  10 controls) were used for estimating 
the concentration of Immunoglobulin's(Ig 
G ,Ig M ,Ig A) . 
Methods : 
Determination of serum levels of  IgA, IgM, 
,and  IgG, by single  radial immune 
diffusion (SRID) plate 
A-Principle 
Kit of (Immunoglobulins IgA, IgG, and 
IgM) provided by CUSABIO company  . 
The  total serum level of  immunoglobulins   
(IgM  , IgG , IgA ) was determined by 
means of  Single  Radial  Immune 
diffusion  Assay . It is a  single  radial  
immune diffusion  test , which was 
developed by Mancini et al., 
[30]
 for  
quantitative  determination of proteins in 
the serum .Test sample is added to a well   
in  an  agarose  gel  containing  a 
monospecific antiserum . The sample  
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diffuses radially through the gel and the 
substance being assayed forms a 
precipitation  ring  with the monospecific 
antiserum . Ring diameter is measured and 
the concentration is determined from the 
reference standard curve. 
B-Procedure 
     Before starting the assay , the plates 
were opened and left for 5 minutes at room 
temperature (18-25
°
 C),  and then 5 ml of 
serum was dispensed into well in the plate  
. The plate was incubated in flat  position  
at room temperature to 48 hours for  ( IgG 
,IgA) and to 72 hours for (IgM). The rnig 
diameter was measured  by an ocular  and 
the concentration was obtained the 
reference curve . 
Hank s  Balanced salt solution (HBSS) 
     Prepare this solution according to 
[31]
  
that contains calcium ions Ca + + and Mg 
Mg + + dissolving substances  in 1000 ml 
of distilled water and adjust the pH to (PH 
7.2) and  divided to the volumes are equal 
and then sterilized By autoclave then save 
in temperature (4 ° C) for use when. 
Killed  Yeast Suspension   
was prepared for the purpose of studying 
the process  of Phagocytosis  and as the 
following  step  :-                                                                                                                     
1- Dry bread Saccharomyces cervisia 
yeast was used  . 
2- 10 grams of the killed yeast was 
suspended in 150 ml of normal saline .  
    3- The suspension was placed in a 
boiling water bath for an hour and then it 
lifted  until get                                  cold 
then filtered via a dual-layer sterile gauze.                          
4- The stuck suspension was divided  
into many test tubes (5 mL) , stored in (- 
20 C°) until used , and The use melted 
when stuck in a water bath (37 m ˚) and 
washing twice before use by using a 
normal, saline 
[32]
 . 
 Wright' s stain  : 
     The  testing  equipment ( kit) was  used 
for Wright 's stain which consist of fixative 
solution and Eosine  Stain  and solution of 
methylene blue which  is produced by 
syrbio company form republic of Arabia 
Syria . 
Phagocytosis  Procedure :  
      The procedure carried out according  
Met-Calf et al., 
[33]
 as follow: 0.025 ml of 
the collected blood was put in plane tube  , 
then added  for  it 0.05 ml from Killed 
yeast  suspension  which prepared by 
soluble  10 grams  of  Saccharomyces   
ceversiae  yeast made in Turkish  
pakamaya  company  in 150 milliliters of 
normal saline  and put suspension in water 
bath for 60 minutes , then this suspension 
was filtered after  it's  cooling . 
      0.025 ml of HBSS were  added to the 
mixture and incubated at 37 C  ْ   for 30 
minutes  . One drop of the mixture  was 
placed on a slid and smeared, then left to 
dry , fixed by methyle  alcohol (99%) for 
min  and stained for 20 min with  Wright 
stain . then , examined  under oil 
immersion . 
                             No. of phagocytic cells 
 Phagocytosis index  =                                         × 100 
                        Total number of cells                    
 Hematological assay : 
The hematological tests that included 
(differential WBCs counts ) were done by 
using Genux  Auto Hematology Analyzer 
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in which the results read and printed 
automatically .  
Statistical analysis : The analysis of data 
were expressed as mean  SD. The 
comparisons between each T1DM patients 
group with  matched healthy control were 
performed with T-test  by using 
computerized Minitab 14 program. P<0.01 
was considered to be the least limit of 
significance, the statistical analysis were 
done by using Pentium-4 computer through 
the ( SPSS program) Statistical Package 
For Social Sciences (version-20).  
 
Results: 
RBCs , Hb ,PCV count : 
      Did not show the results of the current 
study in table (1) , no significant 
differences(p ≤ 0.05 ) in blood  pictures of 
patients and healthy control group. The red 
blood cells ( RBCs) count , hemoglobin 
concentration (Hb) and packed cell volume  
(PCV) percentage  in T1DM  compared 
with the healthy control group, where the 
RBCs mean were (4.92) X10
6
cell/ml for 
patients and (4.83) X10
6
cell/ml for healthy 
control group respectively , while  the 
hemoglobin concentration were (13.58) g 
/dl for patients and (13.07) g /dl for healthy 
control group respectively . The PCV 
percentage  was (40.04)% for patients and 
(40.86)% for healthy control group 
respectively . 
Phagocytic index :  
     The results of the current study showed 
high significant difference (p ≤ 0.001) in 
the rate of phagocytosis, as it decreased the 
rate of phagocytosis in Type I diabetes 
patients to (30.67) compared to the healthy 
controls group, and that the rate of 
phagocytosis (46.98) , as the table (1) 
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some hematological parameters of T1DM patients and  healthy control Table(1) : Shows 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (1): Phagocytosis of yeast cell  by Phagocytic cell 1000 x. 
 
WBCs , Lymphocyte , MID , Neutrophil 
count : 
      The results of the current study showed 
high significant difference (p ≤ 0.001) 
between the two groups of -patients 
compared with healthy controls that has 
been shown in Table  (2) .The WBCs 
count, lymphocytes , MID ,and neutrophil 
in T1DM  compared with the healthy 
control group,  WBCs count there means 
were (7.75) for patients and (5.80) for 
healthy controls group respectively ,while 
lymphocytes means were (16.68) for 
patients and (26.30) for healthy control 
group respectively , the  monocytes , 
eosinophils , and basophils (MID )  means 
were (7.85) for patients and (6.40) for 
Parameter Subject No. Mean    SD  T-value df P-value 
RBC 
Pateints 100 4.92   3.89
0.81 
 
128 
0.271 
Control 30 4.83  3.49  
Hb (g /dl) 
Pateints 100 13.58  1.50  
 
5.52 
 
128 
0.082 
Control 30 13.07  0.94  
PCV (%) 
Pateints 100 40.04  3.73  
1.101 
 
128 
0.273 
Control 30 40.84   2.34 
Phagocytosis 
Patients 100 30.67   14.20
0.99 128 0.001 
Control 30 46.98   10.89
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healthy control group respectively 
,eventually the neutrophils   there were 
have high significant difference too , and 
the means were(5.623) for patients , and 
(3.710) for healthy control group . 
Table(2) :Hematological parameters in T1DM patients and healthy control group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion: 
 
       The results of the current study 
showed a lack of significant difference (P 
˃ 0.05) in each of the concentration of 
hemoglobin between the two groups of 
patients (13.58 ± 1.50) and healthy control 
group (13.07 ±0.94), and the percentage  of 
the R.BC in  patients (4.92 ± 3.89) and 
healthy control (4.83 ± 3.49), the PCV 
value (40.04 ± 3.73) for patients and 
(40.84 ± 2.34) for healthy control ,These 
findings  agree with a studies of  
[34,35,36]
 . 
and attributed the lack of significant 
differences to the high level of sugar in the 
blood does not affect the affectiveness of 
red blood cells and  it ability, as well as 
R.B.C  membrane not effect and  nor old, 
and this is reflected in the level of Hb 
,RBC and PCV, there has been no change 
in rates 
[35]
 . either phagocytosis which is  
 
 
 
the first line of defense against injury  and 
carried out by Neutrophil and Macrophage 
and  Dendritic cells 
[37]
 , which should 
migrate to the places of injuries or 
infections in order to do its job and be the 
migration process in response to some of 
the attraction of chemical 
[38]
 . and 
phagocytosis and one of Non-specific 
immune mechanism and motivated by the 
entry of foreign bodies  
[39]  .                                              
                                     
      The current results showed the  
significant difference( P ˂ 0.001)  as the 
percentage of phagocytosis in patients with 
diabetes mellitus type I (30.67 ± 14.20 ) 
compared to a  healthy control (46.98 ± 
10.89) and these findings are agree with 
the results of a studies 
[40,41,42,43]
 ,  where 
the lack of insulin led to use fatty acids as 
an alternative to glucose and this may 
cause the formation of large amounts of 
ketone bodies that cause the occurrence of 
Parameter Subject No.  Mean    SD  T-value  df P-value 
WBC 
Total count 
Pateints 100 7.75   2.03
1.82 
 
128 
0.001 
Control 30 5.80  1.82 
No. of MID  
Pateints 100 7.85  1.73 
0.88 
 
128 
 
0.001 
Control 30 6.40  2.17 
No. of 
lymphocytes 
Pateints 100 16.68  4.06  
35.90 
 
128 
0.001 
Control 30 26.30  7.77 
No of 
Neutrophils 
Pateints 100 5.623  1.118  
8.73 
 
128 
 
0.001 
Control 30 3.710  0.784  
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ketoacidosis 
[44]
 , and which is 
accompanied by much of the metabolic 
changes such as loss of water and some 
ions and this causes stop metabolism of 
glucose  is the main source of energy 
[45]
 .   
The high level of sugar leads to the flow of 
calcium ions Ca + + to neutrophils and the 
continued flow inhibits the oxidation 
process in mitochondria and thus lower 
production (ATP) which causes low 
activity of enzymes responsible for the 
entry and exit of calcium ions to the cells, 
and this weakens the activity process of 
phagocytosis, so given diabetic patients 
drugs depressor Sugar where lead to a 
reduction of the level of calcium ions and 
increase the production of the (ATP) and 
improve the process of phagocytosis 
[46]
,  
and also found that there is a functional 
failure occurs in the organelles of energy 
and this directly affects the process of 
phagocytosis [47], and that the high level 
of sugar inhibits the enzyme Glucose 6-
phosphate dehydrogenase, which reduces 
the production of ultra-oxygen 
[48]
 , and 
that the damage to the Fc receptor for IgG 
on the surface of neutrophil cells cause low 
phagocytosis 
[49]
                              .                                                                                            
         Showed the results of the current 
study, high significant differences ( p ≤ 
0.001) in total count of white blood cells 
from the patient group (7.75±2.03) and the 
control group (5.80±1.82), and these 
findings are degree with the results studies 
of each 
[43,50,51]
  .  The reason for increasing 
white blood cells in patients with Type I 
diabetes is due to the increased number of 
granular W.B.Cs (neutrophil, acidophil, 
basophil (MID)) compared to the healthy 
control group. The reason for the increase 
is the rise in the number of neutrophils and 
this study are degree  with 
[52,53]
 . And that 
this increase is occurring as a result of the 
inhibition of neutrophil cells migration to 
the site of infection or inflammation 
[54,55,56]
 . And inhibit antigen pancreatic cell 
migration neutrophil in diabetes type I and 
then accumulate in the bloodstream and 
increase their numbers 
[57]
, and may be the 
chemical factor inhibitory formation  
proteins plasma compete attraction 
chemical derived from complement 
receptor cells of neutrophil, and this 
competitive inhibition is inhibits the 
chemical response of neutrophil cells 
[58]
 , 
that the high level of sugar prevent the 
migration of neutrophils because of its 
effect on the process of chemotactic or gets 
direct interaction between the sugar 
glucose and receptors on the surface of 
neutrophils 
[59]
, or perhaps get the 
breakdown of some blood proteins and 
when the correlation of these proteins with 
the surface receptor neutrophil cells get 
inhibition for chemotactic and inhibition  
neutrophil migrate  
[60]
, that the high level 
of sugar has a detrimental effect on the 
functions of neutrophils in several 
important stages (chemotactic , adhesion, 
phagocytosis) 
[61]
,  because it causes cross 
the amounts of sugar across the cell 
membrane of neutrophil by diffusion 
without the mediation of insulin and this in 
turn causes disorder in the process of 
glycolysis 
[62]
, because the enzymes of 
glycolysis independent  on insulin like 
(PFK) PhosphoFructoKinase and Pyruvate 
kinase enzyme and become ineffective 
which requires the occurrence of alteration 
in glucose metabolism, causing weakness 
of the process of glycolysis and decrease  
in energy production necessary for the 
neutrophil cells 
[63,64]
 . As the decrease in 
the ability of neutrophil adhesion and 
failing to increase its ability to kill bacteria 
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due to the effects of direct and indirect to 
the hormone insulin 
[65]
.                         
Showed the results of the current study, 
high significant difference ( p ≤ 0.001) in 
the concentration of immunoglobulins ( 
IgM, IgG, IgA) in a patients group with 
diabetes type I compared a healthy control 
group, where the concentration of IgG 
(1562.385 ± 458.127) of the patients, while 
the healthy control is (972.420 ± 223.375), 
and  IgA (359.560 ± 148.779)  for patients  
and (129.420 ± 62.809) for healthy control 
, as well as IgM (303.540 ± 79.618) for 
patients and  (186.090 ± 39.061) for 
healthy control                              .                                        
The results of this study agree with the 
results of a studies  each of 
[66,67,68]
, as well 
as the results of this study are agree with 
the results of a study 
[69]
, which was carried  
in India, as well as with the study 
[70]
,that 
was carried  in Saudi Arabia. These studies 
all indicated to the high level of 
immunoglobulins in chronic diseases such 
as type I diabetes and bacterial infections. 
As well as the study carried out by each of 
[71,72]
, which indicated a high level of 
immunoglobulins in patients with diabetes 
. The IgA increase with diabetes patients  
and those who suffer from complications 
in kidney and arteries, high blood pressure 
and bacterial infections and acute and 
chronic diabetic patients with 
inflammatory of urinary tract 
[73]
  .  The 
IgG increase  in patients with diabetes  
patients  , particularly type I more prepared 
for infections  than individuals' natural 
[74,75]
, it is likely that diabetes effects on the 
body's immunity through inhibition of the 
effectiveness of immunoglobulin without 
reduce its concentration and this is 
happening in the process of phagocytosis 
[76] 
. And diabetic patients suffering from 
acute and chronic injuries, and this 
corresponds with a high level of IgG 
antibody, which is basic in 
chronicinfections and the level of IgM in 
acute injuries 
[77]
 .        
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  : الخلاصة                                                                                                                                      
قار، خلال الفترة من  ذي  لصماء في مديرية الصحة في محافظةوقد أجريت الدراسة الحالية في مركز السكري والغدد ا
السكري النوع الأول عن طريق قياس  داء مرضىل. تهدف دراسة وتقييم الحالة المناعية 4102لى مايو إ 3102أكتوبر 
طريقة الانتشار المناعي الاشعائي المفرد  ) من خلال  AgI, MgI, GgIة المناعي اتولينيلوبجمستويات المناعية (الال
خلايا الدم عد  وشملت الدراسة اختبار الخلايا البلعمية على البلعمة (معامل البلعمة) وقياس المعايير الدموية ( , )DIRS(
خلايا الدم البيضاء). وشملت الدراسة ما مجموعه التفريقي ل وعد كريات الدم المضغوطة  ، الهيموجلوبين، حجم الحمراء 
-1إناث) و تتراوح أعمارهن بين  94ذكور) و ( 15(السكري النوع الاول من الاصابة بداء  المرضى الذين يعانون  001
داء السكري  عينة من مرضى 02في المصل لمدة ) )AgI, MgI, GgI(قياس تركيز  عاما. تم قياس مستويات المناعية 04
تحليل الإحصائي ائج ال. أظهرت نتسيطرةالأصحاء في المجموعة ال عينات من الأشخاص 01 وكذلك درست  ،النوع الاول 
السكري  داء في مرضىAgI, MgI ,GgI( (  ة المناعي اتولينيلوبجالمستوى  ) في 100.0 ≤ Pعالية ( معنويةزيادة 
) في جميع المرضى الذين 100.0 ≤ P. وكان انخفاض معامل البلعمة معنويا (لسيطرة لأول مقارنة مع مجموعة االنوع ا
د أوضحت قفالدموية  بالمعاييرفيما يتعلق  اما  مجموعة  السيطرة، ة مع مقارن ول النوع الا السكري داء  يعانون من مرض
والهيموجلوبين  عد كريات الدم الحمراء  في معدلات )50.0 ≤ P( معنوية  نتائج الدراسة الحالية، عدم وجود فروق
الدم  كريات د معدل عد ، كما زاسيطرةارنة مع مجموعة البالمق  الأولالنوع  السكري  داء  مرضى في كل VCPو
) في المرضى الذين يعانون من مرض السكري 100.0 ≤ P( ة قعدة، والوحيدال، ة ، والحمضالخلايا اللمفاوية البيضاء و
 .لسيطرة شخاص الأصحاء في المجموعة امن النوع الأول مقارنة مع الأ
 
